Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs MAP Boga Adiperkasa Tbk. (MAPB) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
MAP Boga Adiperkasa Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs MAP Boga Adiperkasa Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp234 (market cap 316.25B, 16.6K 24h volume), while MAP Boga Adiperkasa Tbk. trades at Rp1,115 (market cap 2.66T). The key difference: MAP Boga Adiperkasa Tbk. is far larger — about 8.4× Diagnos Laboratorium Utama Tbk.'s market cap. Which is the better fit depends on your goals.

DGNSMAPB
Market Cap
316.25B2.66T
Volume
16.6K
Lot
166
Turnover
3.83M
Average Price
230.78
Value
3.83M
Indicative Equilibrium Price
2301,120
Indicative Equilibrium Volume
2.4K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
MAPB
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About MAP Boga Adiperkasa Tbk.

PT. Map Boga Adiperkasa (formerly PT. Creasi Aksesoris Indonesia) (the Company) was established based on notarial deed No. 01 dated January 7, 2013 of Lilis Sugianto, S.H., notary in Jakarta.

Read more on MAPB